Host Transcriptomic Response Following Administration of Rotavirus Vaccine in Infants' Mimics Wild Type Infection

Alberto Gómez-Carballa1,2,3, Ruth Barral-Arca1,2,3, Miriam Cebey-López1,2,3

  • 1Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS) and Universidad de Santiago de Compostela (USC), Santiago de Compostela, Spain.

Frontiers in Immunology
|February 8, 2021
PubMed

Insights

Rotavirus (RV) vaccination and infection induce similar transcriptome changes in children. A nine-transcript signature can differentiate vaccinated from infected or healthy children, aiding vaccine development.

Area of Science:

  • Immunology
  • Virology
  • Transcriptomics

Background:

  • Rotavirus (RV) is a significant global cause of childhood illness and death.
  • The precise immunological mechanisms of RV vaccine protection remain unclear.

Purpose of the Study:

  • To compare the transcriptomes of children with natural RV infection versus those vaccinated with RotaTeq®.
  • To identify molecular signatures differentiating RV infection, vaccination, and healthy states.

Main Methods:

  • Transcriptome analysis of children with community-acquired RV infection and RV-vaccinated children.
  • Application of machine learning to identify differentiating gene expression patterns.

Main Results:

  • RV vaccination elicits transcriptome changes similar to natural RV infection, involving cell cycle and gastrointestinal pathways.
  • A nine-transcript signature accurately distinguishes vaccinated from naturally infected children (AUC: 90%) and infected from healthy children (AUC: 100%).
  • A specific microRNA, hsa-mir-149, was identified with a potential role in host defense against viral pathogens.

Conclusions:

  • RV vaccination mimics natural infection at the transcriptomic level.
  • The nine-transcript signature may serve as a biomarker for vaccine-induced protection and differentiate infection statuses.
  • Findings may inform the development of improved RV vaccines and antiviral therapies, and elucidate links to intussusception.
Abstract